TP53 and Wilms tumor: We suggest that the number of Wilms' tumor specimens to be evaluated should be increased in future studies, especially those from patients with unfavorable histology and advanced stage disease, and that more comprehensive studies should be performed by analyzing the remaining coding exons of the p53 gene and their expression, in order to better determine any possible association between alterations of p53 gene and Wilms' tumor.